Breadcrumb
Researchers - Title

Research - Our Team

PeopleCategories
People
GUILLERMO MENA

GUILLERMO MENA

Associated researcher Malaria and Neglected Parasitic Diseases

Guillermo Mena (MD, PhD) has clinical, research, and teaching experience in both public and private institutions. His work is focused on hospital preventive medicine and the epidemiology of communicable diseases. He is currently based at Hospital Clínic of Barcelona. 

Lines of research

  • Vaccination
  • Communicable diseases

Main publications

  • Meeraus W, de Munter L, Gray CM, Dwivedi A, Wyndham-Thomas C, Ouwens M, Hartig-Merkel W, Drikite L, Rebry G, Carmona A, Stuurman AL, Chi Nguyen TY, Mena G, Mira-Iglesias A, Icardi G, Otero-Romero S, Baumgartner S, Martin C, Taylor S, Bollaerts K. Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis. Lancet Reg Health Eur. 2023 Jul 1;31:100675.
  • Mena G, Casas I, Casañ C, Auñón M, Matas L, Mòdol JM, Esteve M. Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season. PLoS One. 2021 Dec 2;16(12):e0260397. 
  • Llupià A, Mena G, Olivé V, Quesada S, Aldea M, Sequera VG, Ríos J, García-Basteiro AL, Varela P, Bayas JM, Trilla A. Evaluating influenza vaccination campaigns beyond coverage: a before-after study among health care workers. Am J Infect Control. 2013 Aug;41(8):674-8. 
  • Mena G, Llupià A, García-Basteiro AL, Sequera VG, Aldea M, Bayas JM, Trilla A. Educating on professional habits: attitudes of medical students towards diverse strategies for promoting influenza vaccination and factors associated with the intention to get vaccinated. BMC Med Educ. 2013 Jul 18;13:99. 
  • Mena G, García-Basteiro AL, Llupià A, Díez C, Costa J, Gatell JM, García F, Bayas JM. Factors associated with the immune response to hepatitis A vaccination in HIV-infected patients in the era of highly active antiretroviral therapy. Vaccine. 2013 Aug 12;31(36):3668-74. 
Asset Publisher